TP53 and malignant colon neoplasm: The transcription of SOCS2 was repressed by wild type p53, and it promoted proliferation, anchorage independent growth, resistance against basal and drug induced apoptosis, and tumor growth in xenograft assays in prostate and colon cancer cell lines23–25.